{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:43:27Z","timestamp":1790120607799,"version":"4.0.1"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>\n            Current therapies against invasive pulmonary aspergillosis (IPA) have a limited cure rate. Given that a delay in treatment initiation may be fatal, a new drug with rapid-onset and potent fungicidal activity is needed. The novel cyclic hexapeptide ASP2397 (currently known as VL-2397) exhibited antifungal activity against\n            <jats:named-content content-type=\"genus-species\">Aspergillus fumigatus<\/jats:named-content>\n            (including azole-sensitive and azole-resistant isolates),\n            <jats:named-content content-type=\"genus-species\">A. terreus<\/jats:named-content>\n            , and\n            <jats:named-content content-type=\"genus-species\">A. flavus<\/jats:named-content>\n            at an MIC range of 1 to 4\u2009\u03bcg\/ml in human serum.\n          <\/jats:p>","DOI":"10.1128\/aac.02689-18","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T09:33:34Z","timestamp":1565256814000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":42,"title":["ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against\n            <i>Aspergillus<\/i>\n            Species through a Specific Transporter"],"prefix":"10.1128","volume":"63","author":[{"given":"Ikuko","family":"Nakamura","sequence":"first","affiliation":[{"name":"Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ohsumi","sequence":"additional","affiliation":[{"name":"Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinobu","family":"Takeda","sequence":"additional","affiliation":[{"name":"Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7726-7892","authenticated-orcid":false,"given":"Kiyomitsu","family":"Katsumata","sequence":"additional","affiliation":[{"name":"Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souichiro","family":"Akamatsu","sequence":"additional","affiliation":[{"name":"Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Mitori","sequence":"additional","affiliation":[{"name":"Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakai","sequence":"additional","affiliation":[{"name":"Drug Discovery Research, Astellas Pharma Inc., Ibaraki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206291"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004404"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw444"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00001011"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990330"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000005"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.11.118"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2014.06.001"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02478-15"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)82003-6"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2016.106"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.2.310"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.1.44-69.2005"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2005.06.007"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2007.tb04000.x"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.6.731"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2016.107"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02336-15"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.2.229"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.44.8.2017-2022.2000"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.137-142.2004"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00931-09"},{"key":"e_1_3_3_24_2","volume-title":"Prescribing information for Noxafil","author":"Merck & Co., Inc","year":"2017","unstructured":"Merck & Co., Inc. 2017. Prescribing information for Noxafil. Merck & Co., Inc., Whitehouse Station, NJ."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2333"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh055"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2011.577822"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01556-08"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01462-15"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.4.539"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.45.26723"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.phyto.45.062806.094338"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R111.311829"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.14.10709"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00301-11"},{"key":"e_1_3_3_36_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard","author":"CLSI","year":"2002","unstructured":"CLSI. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 2nd ed, M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.","edition":"2"},{"key":"e_1_3_3_37_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard","author":"CLSI","year":"2008","unstructured":"CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, 2nd ed. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"2"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2013.57"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.44.3.619-621.2000"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2010.03.010"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02689-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02689-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:38:46Z","timestamp":1645479526000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02689-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1128\/AAC.02689-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.02689-18","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"2019-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02689-18"}}